
Pfizer revealed in its briefing on its second quarter financials that Ibrance, its breast cancer treatment, had grown in sales …

Pfizer has had a tough time keeping hold of its Vice President’s involved in R&D of late, losing high-profile researcher, …

It’s been a rollercoaster week for AstraZeneca.

Boehringer Ingelheim announced that it had broken ground on its planned $217 million upgrade and expansion of its existing Fermont …

As of today, all babies born in the UK will be administered with the vaccine for hepatitis B, with the …

Torbay Pharmaceuticals conducted a grand unveiling to open its £26 million pharmaceuticals manufacturing unit – the largest NHS manufacturer of …

The reputation of large pharma companies in the UK was revealed to be well below the global average, in PatientView’s …

Through digital media and technology, the patient’s voice is only growing in strength and it is of growing importance that …

Researchers have found that offering first-time patients a HIV test in an area of high-prevalence could help reduce levels of …

The FDA has reputation worldwide as being a standard bearer when it comes to regulating the safety of products and …

Jeremy Hunt has unveiled a plan to boost recruitment of mental health staff by using £1 billion in funds to …

A study published in the BMJ displayed the large degree of variation and lack of industry-standard when it comes to …

Pharmafile spoke to National Cancer Institute’s (NCI) Jason Christofaro and Sherry Ansher regarding the development of an agent formulary and its role …

It’s Friday, and it’s been a week characterised by a range of promising research results, particularly into HIV and Duchenne …

The WHO has released a report on the state of hepatitis prevention and treatment to mark World Hepatitis Day, with …